Short chemotherapy-phased imatinib (IM) pulses improve long-term outcome of adult patients with philadelphia chromosome-positive acute lymphoblastic leukemia (PH+ ALL)

Bassan, R.; Rossi, G.; Pogliani, E.M.; Di Bona, E.; Angelucci, E.; Cavattoni, I.; Cortelezzi, A.; Gianfaldoni, G.; Levis, A.; Ciceri, F.; Mattei, D.; Borlenghi, E.; Terruzzi, E.; Borghero, C.; Romani, C.; Spinelli, O.; Tosi, M.; Oldani, E.; Intermesoli, T.; Rambaldi, A.

Short chemotherapy-phased imatinib (IM) pulses improve long-term outcome of adult patients with philadelphia chromosome-positive acute lymphoblastic leukemia (PH+ ALL) / R. Bassan, G. Rossi, E.M. Pogliani, E. Di Bona, E. Angelucci, I. Cavattoni, A. Cortelezzi, G. Gianfaldoni, A. Levis, F. Ciceri, D. Mattei, E. Borlenghi, E. Terruzzi, C. Borghero, C. Romani, O. Spinelli, M. Tosi, E. Oldani, T. Intermesoli, A. Rambaldi. - In: BLOOD. - ISSN 0006-4971. - 114:22(2009), pp. 2029-2029. ((Intervento presentato al 51. convegno Annual Meeting of the American Society of Haematology tenutosi a New Orleans nel 2009.